Relationship between matrix metalloproteinase-9 and common carotid artery intima media thickness

Maged Abdelnaseer1, Nervana Elfayomi1, Eman H Esmail2

  • 1Neurology Department, Cairo University, 49 Misr Hilwan Elzraai Street, Maadi, Cairo, 2218, Egypt.

Insights

Matrix metalloproteinase-9 (MMP-9) serum levels correlate with carotid intima-media thickness (IMT) in stroke patients and asymptomatic individuals. This suggests MMP-9 may be a therapeutic target for preventing strokes.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Biochemistry

Background:

  • Atherosclerosis is a major cause of death and disability.
  • Carotid intima-media thickness (IMT) is a predictor of ischemic stroke.
  • Matrix metalloproteinases (MMPs), particularly MMP-9, are implicated in atherosclerosis and represent potential therapeutic targets.

Purpose of the Study:

  • To investigate the relationship between serum matrix metalloproteinase-9 (MMP-9) levels and common carotid artery intima-media thickness (CCA-IMT).
  • To compare this relationship in patients with ischemic stroke versus asymptomatic subjects.

Main Methods:

  • Recruited 30 ischemic stroke patients and 30 asymptomatic volunteers.
  • Assessed vascular risk factors, serum MMP-9 levels, and bilateral CCA-IMT.
  • Analyzed correlations between serum MMP-9 and CCA-IMT, adjusting for risk factors.

Main Results:

  • A significant positive correlation was found between CCA-IMT and serum MMP-9 in asymptomatic subjects (p=0.000).
  • This correlation was significant for the right CCA (p=0.023) but not the left (p=0.0284) in stroke patients.
  • Fasting blood sugar correlated with MMP-9 in asymptomatic subjects (p=0.005) but not in patients. No correlation with age or other risk factors was observed.

Conclusions:

  • Serum MMP-9 is positively correlated with CCA-IMT in both stroke patients and asymptomatic individuals.
  • MMP-9 may serve as a potential biomarker and therapeutic target for stroke prevention strategies.